candesartan cilexetil has been researched along with desoxycorticosterone in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inada, Y; Ishimura, Y; Kanagawa, R; Nishikawa, K; Wada, T | 1 |
| Chatani, F; Hamaguchi, A; Inada, Y; Ishimura, Y; Kim, S; Miura, K; Ohta, K; Omura, T; Wada, T; Yukimura, T | 1 |
| Fujita, H; Itoh, H; Kawa, T; Miki, S; Morimoto, S; Nakagawa, M; Nakata, T; Sasaki, S; Takeda, K; Uchida, A | 1 |
| Brown, L; Duce, B; Miric, G; Sernia, C | 1 |
| Kageyama, J; Kataoka, H; Makino, H; Ogura, T; Otsuka, F; Sato, M; Yamauchi, T | 1 |
| Hara, K; Kobayashi, N; Matsuoka, H; Tsubokou, Y; Watanabe, S | 1 |
6 other study(ies) available for candesartan cilexetil and desoxycorticosterone
| Article | Year |
|---|---|
Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Administration, Oral; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Desoxycorticosterone; Disease Models, Animal; Enalapril; Hypertension; Kidney; Male; Rats; Rats, Wistar; Receptors, GABA-A; Renin-Angiotensin System; Sodium Chloride; Tetrazoles | 1995 |
Role of angiotensin II in renal injury of deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin II; Animals; Benzimidazoles; Biphenyl Compounds; Collagen; Desoxycorticosterone; Enalapril; Hypertension; Kidney; Kidney Diseases; Male; Organ Size; Rats; Rats, Wistar; Renin; RNA, Messenger; Sodium Chloride; Tetrazoles; Transforming Growth Factor beta | 1994 |
Chronic angiotensin blockade with candesartan cilexetil in DOCA/salt hypertensive rats reduces cardiac hypertrophy and coronary resistance without affecting blood pressure.
Topics: Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Desoxycorticosterone; Hypertension; Male; Rats; Rats, Wistar; Sodium, Dietary; Systole; Tetrazoles; Vascular Resistance | 1997 |
Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Captopril; Collagen; Desoxycorticosterone; Endomyocardial Fibrosis; Fibronectins; Heart; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System; Sodium, Dietary; Spironolactone; Tetrazoles | 1999 |
Chronic treatment with angiotensin II type 1 receptor antagonist suppresses glomerular activator protein-1 activity in salt-sensitive hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Cell Nucleus; Chronic Disease; Cilazapril; Desoxycorticosterone; Electrophoresis; Heart Rate; Hypertension; Kidney Glomerulus; Proto-Oncogene Proteins c-fos; Rats; Rats, Inbred Dahl; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Transcription Factor AP-1 | 2000 |
Effects of quinapril on expression of eNOS, ACE, and AT1 receptor in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Body Weight; Desoxycorticosterone; Hemodynamics; Hypertension; Isoquinolines; Myocardium; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Organ Size; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; RNA, Messenger; Sodium Chloride; Tetrahydroisoquinolines; Tetrazoles; Ventricular Function, Left; Ventricular Remodeling | 2001 |